Get the Stockscreener App
3.89
1.27%
-0.05
After Hours:
3.88
-0.01
-0.26%
Apyx Medical Corp stock is traded at $3.89, with a volume of 56,853.
It is down -1.27% in the last 24 hours and up +13.74% over the past month.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Surgical Aesthetics and Original Equipment Manufacturing (OEM). Its Surgical Aesthetics segment derives the majority of its revenue.
See More
Previous Close:
$3.94
Open:
$4
24h Volume:
56,853
Relative Volume:
0.45
Market Cap:
$162.72M
Revenue:
$52.84M
Net Income/Loss:
$-11.11M
P/E Ratio:
-14.19
EPS:
-0.2742
Net Cash Flow:
$-9.12M
1W Performance:
+5.99%
1M Performance:
+13.74%
6M Performance:
+90.22%
1Y Performance:
+186.03%
1-Day Range:
$3.7401
$4.01
1-Week Range:
$3.35
$4.18
52-Week Range:
$0.7554
$4.50
Apyx Medical Corp Stock (APYX) Company Profile
Name
Apyx Medical Corp
Sector
Industry
Phone
(727) 384-2323
Address
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
3.89 | 164.81M | 52.84M | -11.11M | -9.12M | -0.2742 |
ABT
Abbott Laboratories
|
104.83 | 180.82B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
327.65 | 125.72B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
87.89 | 111.16B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.78 | 101.28B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.67 | 47.45B | 6.07B | 1.06B | 1.34B | 1.8063 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-11-26 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-16-25 | Initiated | Roth Capital | Buy |
| Nov-14-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Nov-12-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Oct-17-24 | Initiated | BTIG Research | Neutral |
| Jul-14-23 | Initiated | Stephens | Overweight |
| May-20-22 | Initiated | Lake Street | Buy |
| Apr-02-19 | Reiterated | Dougherty & Company | Buy |
View All
Apyx Medical Corp Stock (APYX) Latest News
APYX Medical Corp (NASDAQ:APYX) Meets Minervini Trend Template with High-Growth Momentum - ChartMill
If You Invested $1,000 in Apyx Medical Corporation (APYX) - Stock Titan
Apyx Medical (APYX) SVP exercises stock options to acquire 37,000 shares - Stock Titan
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Apyx Medical Calls AYON a “Game Changer” at Citizens Conference, Targets Profitability in 2025 - Yahoo Finance
Apyx Medical Corporation 2025 Annual Report: Innovation in Surgical Aesthetics, AYON Launch, and Global Expansion - Minichart
APYX: Craig-Hallum Raises Price Target, Maintains "Buy" Rating | - GuruFocus
Apyx Medical (NASDAQ:APYX) Stock Price Expected to Rise, Craig Hallum Analyst Says - MarketBeat
Apyx Medical at Citizens Life Sciences Conference: AYON’s Market Potential - Investing.com
Apyx Medical Corporation (NASDAQ:APYX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Apyx Medical (NASDAQ:APYX) Upgraded to Buy at BTIG Research - MarketBeat
This JM Smucker Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday - Benzinga
BTIG upgrades Apyx Medical stock rating on GLP-1 demand growth - Investing.com India
Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25 - AlphaStreet
AYON launch and cost cuts shape Apyx Medical (NASDAQ: APYX) 2025 - Stock Titan
Apyx Medical 2025 10-K: $52.8M Revenue, $(0.27) EPS - TradingView
Apyx Medical 2025 Financial Results: Revenue Growth, Segment Performance, and Key Financial Highlights - Minichart
Apyx Medical earnings beat by $0.03, revenue topped estimates - Investing.com
Apyx Medical (APYX) Q4 Revenue Jumps 34.8% to $19.2M, Loss Narrows to $0.06/Share - AlphaStreet
Apyx Medical Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Apyx Medical Q4 2025 revenue beats forecast, stock rises - Investing.com
APYX MEDICAL ($APYX) Releases Q4 2025 Earnings - Quiver Quantitative
Apyx Medical (NASDAQ:APYX) Announces Quarterly Earnings Results - MarketBeat
Apyx Medical Reports Q4 Revenue of $19.2M, Full-Year 2025 Revenue $52.8M; FY2026 Revenue Guidance $57.5M–$58.5M - TradingView
Apyx Medical (NASDAQ: APYX) grows 2025 sales and sharply narrows loss - Stock Titan
Apyx’s new AYON body contouring system drives 34.7% Q4 sales jump - Stock Titan
A Preview Of Apyx Medical's Earnings - Benzinga
Aug Setups: Is Apyx Medical Corporation currently under institutional pressureJuly 2025 Catalysts & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Aug Big Picture: What dividend growth rate does Apyx Medical Corporation offerWeekly Trend Report & AI Enhanced Trading Signals - baoquankhu1.vn
Apyx Medical (APYX) to Release Quarterly Earnings on Thursday - MarketBeat
APYX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Should You Buy Apyx Medical Inc (APYX) Today? Analysis, Price Targets, and 2026 Outlook. - Intellectia AI
Breakout Watch: Can Apyx Medical Corporation keep up with sector leadersTrend Reversal & Daily Price Action Insights - baoquankhu1.vn
APYX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Apyx Medical Corporation to Release Fourth Quarter of Fiscal Year 2025 Financial Results on March 10, 2026 - The Manila Times
APYX MEDICAL : TO RELEASE FOURTH QUARTER OF FISCAL YEAR 2025 FINANCIAL RESULTS ON MARCH 10, 2026 - marketscreener.com
Apyx Medical Corporation to Participate in The Citizens Life Sciences Conference - GlobeNewswire
Surgical aesthetics firm Apyx to meet investors, livestream chat from Miami - Stock Titan
Apyx Medical (NASDAQ:APYX) Trading 3.2% HigherHere's What Happened - MarketBeat
Growth Recap: Why is Apyx Medical Corporation stock going upWeekly Profit Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
APYX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Subdued Growth No Barrier To Apyx Medical Corporation (NASDAQ:APYX) With Shares Advancing 26% - simplywall.st
Technical Analysis: Is Apyx Medical Corporation a potential multi baggerJuly 2025 Selloffs & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Apyx Medical Corporation to Participate at the BTIG 13th - GlobeNewswire
Surgical aesthetics maker Apyx heads to BTIG’s 2026 medtech summit - stocktitan.net
Apyx Medical Corporation to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference - Yahoo Finance
Chuck Royce's Recent Transaction with Apyx Medical Corp: An In-D - GuruFocus
How Evolving Valuation Views Are Rewriting The Story For Apyx Medical (APYX) - Yahoo Finance
Apyx Medical Stock Strengthens On AYON Launch And U.S. Aesthetics Demand - RTTNews
Apyx Medical reports 34% revenue growth in Q4 2025 - Investing.com
Quarterly Earnings: How liquid is Apyx Medical Corporation stock2025 Sector Review & Daily Stock Trend Watchlist - baoquankhu1.vn
Apyx Medical Corp Stock (APYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):